AI-generated summary
The authors report results from 241 patients with maxillofacial disorders treated with low-level laser therapy using 632.8, 670 and 830 nm diode lasers at one Brazilian center. At the end of treatment, 154 patients were reported as asymptomatic, 50 improved considerably and 37 remained symptomatic. The abstract describes the study as a case series without a control group, so the findings cannot establish causation.
- Participants
- 241
- Who or what was studied
- 241 patients (205 female, 36 male, ages 7 to 81) with maxillofacial disorders including temporomandibular joint pain, trigeminal neuralgia, muscular pain, aphthae, inflammation, tooth hypersensitivity and small hemangiomas
- Wavelengths
- 670, 830 nm
- Limits stated in the abstract
- The abstract reports an uncontrolled treatment series with no comparison group and provides no information on outcome measurement or statistical analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 1.8 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.